Stem Cell Transplantation

Detection of circulating tumor DNA using immunoglobulin-based next generation sequencing within an apheresis stem cell sample predicted relapse after autologous stem cell transplantation among patients with diffuse large B-cell lymphoma.

Radiation-based approaches may offer an alternative to stem cell transplant for some patients with relapsed or refractory classical Hodgkin lymphoma, according to an analysis presented at ASH Annual Meeting and Exposition.

Healio spoke with Taimur Sher, MBBS, MD, a hematologist, internist and oncologist at the Mayo Clinic Cancer and Multispecialty Amyloidosis Center, about the effects and potential intolerance issues of auto-hematopoietic stem cell transplantation in amyloid light chain (AL) amyloidosis patients.

First-line maintenance therapy with ixazomib extended PFS compared with placebo among certain patients with newly diagnosed multiple myeloma, according to results of the TOURMALINE-MM4 trial published in Journal of Clinical Oncology.

Recent items have discussed a new Iluvien trial and the history of Bausch + Lomb. Check out five popular items from Healio/OSN’s best-performing tweets below:

Cultivated autologous limbal stem cell transplantation was successfully performed at Massachusetts Eye and Ear in four patients with chemical burns.

Autologous stem cell transplant at first remission for untreated transformed indolent B-cell lymphoma improved duration of disease control but showed trends toward worse overall survival, according to a presenter at ASCO2020 Virtual Scientific Program.

An estimated 800 new cases of neuroblastoma are diagnosed in the United States each year.

ORLANDO — The novel antiviral agent letermovir appeared effective for primary cytomegalovirus prevention among haploidentical stem cell transplant recipients, according to results of a single-center chart review presented at TCT | Transplantation & Cellular Therapy Meetings.

Gabriela S. Hobbs, MD, and Oluwatoyosi Adefunke Onwuemene, MD, MS, will participate in the American Society of Hematology-Harold Amos Medical Faculty Development Program.